*** do blood tests detect cancer ***
Cameron Reynolds, chief executive of VolitionRx (NYSE:VNRX), describes company’s cancer blood test as revolutionary as a method of detecting cancer in the early stages and could prove critical for the improvement of patients' survival rates.
Today, Volition Rx reported over 90% accuracy for its new and affordable cancer blood test in a study into colorectal cancer in Belgium.
Its NuQ test identified 23 colorectal cancer sufferers out 121 patients tested.
Video credits to the YouTube channel owner